Sanara MedTech Inc. SMTI Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 92.9%+1.8pp | 92.7%+2.1pp | 92.3%+2.1pp | 91.8%+2.0pp | 91.2%+2.4pp | |
| Operating margin | 6.1%+5.1pp | 4.6%+6.2pp | 5.9%+10.8pp | 3.9%+11.6pp | 1.1%+7.7pp | |
| Net margin | -31.2%-18.8pp | -36.4%-25.3pp | -36.8%-26.1pp | -10.2%-1.2pp | -12.5%-5.3pp | |
| EBITDA margin | 9.3%+2.8pp | 8.5%+4.4pp | 10.7%+10.0pp | 9%+10.8pp | 6.5%+7.2pp | |
| Returns | ||||||
| Return on equity | -153.7%-125pp | -165.7%-143pp | -163.2%-143pp | -25.8%-9.9pp | -28.6%-17.1pp | |
| Return on assets | -40.5%-26.9pp | -46.7%-34.7pp | -47%-36.7pp | -11.5%-2.6pp | -13.7%-6.2pp | |
| Return on invested capital | 12.9%+11.2pp | 10.3%+12.8pp | 12.8%+19.7pp | 6.4%+18.5pp | 1.7%+12.0pp | |
| Efficiency | ||||||
| Asset turnover | 1.3×+0.2× | 1.3×+0.2× | 1.3×+0.3× | 1.1×+0.1× | 1.1×+0.1× | |
| Inventory turnover | 2.4×+0.2× | 2.2×+0.1× | 2.5×+0.6× | 2.3×+0.4× | 2.2×+0.2× | |
| Liquidity | ||||||
| Current ratio | 2.3×-0.5× | 1.8×-0.4× | 1.8×-0.4× | 2.3×+0.5× | 2.8×+1.4× | |
| Quick ratio | 2×-0.5× | 1.6×-0.4× | 1.6×-0.4× | 2×+0.5× | 2.5×+1.5× | |
| Cash ratio | 1×-0.6× | 0.9×-0.1× | 0.9×-0.3× | 1.1×+0.9× | 1.6×+1.3× | |
| Leverage | ||||||
| Debt-to-equity | 6.9×+5.7× | 8.1×+7.3× | 7.7×+6.9× | 1.3×+0.9× | 1.2×+0.9× | |
| Debt-to-assets | 0.7×+0.2× | 0.7×+0.3× | 0.7×+0.3× | 0.5×+0.2× | 0.5×+0.3× | |
| Net debt / EBITDA | 3.5×-0.6× | 3.6×-1.0× | 3×-25.7× | 3.2×— | 4.1×— | |
| Interest coverage | 0.9×+0.7× | 0.7×+1.1× | 1×+2.8× | 0.7×+4.7× | 0.2×+6.3× | |
| Per Share | ||||||
| Book value per share | $0.78-81.7% | $0.69-85.2% | $0.69-85.3% | $4.11-16.5% | $4.28-16.8% | |
| Valuation | ||||||
| Market capitalization | $216.18M-9.7% | $208.65M-28.1% | $282.47M+10.3% | $253.04M+6.5% | $274.8M-13.0% | |
| Enterprise value | $250.95M-6.5% | $240.26M-21.6% | $314.92M+15.9% | $281.53M+12.2% | $298.83M-8.0% | |
| Price / sales | 2×-0.5× | 2×-1.3× | 2.8×-0.5× | 2.6×-0.7× | 3×-1.6× | |
| Price / book | 32.4×+25.3× | 35.1×+27.8× | 45.9×+39.5× | 7.1×+1.5× | 7.5×+0.2× | |
| EV / EBITDA | 26.2×-5.7× | 27.5×-59.0× | 28.9×-469× | 32.1×— | 50.5×— | |
| EV / sales | 2.4×-0.4× | 2.3×-1.2× | 3.1×-0.4× | 2.9×-0.6× | 3.3×-1.5× | |
| Earnings yield | -14.8%-10.8pp | -18%-14.7pp | -13.3%-10.0pp | -3.9%-1.2pp | -4.2%-2.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Sanara MedTech Inc.'s profit margins?
- Sanara MedTech Inc. (SMTI) runs a 92.9% gross margin and a 6.1% operating margin, with a -31.2% net margin.
- Where do Sanara MedTech Inc.'s ratios come from?
- Every ratio is computed from Sanara MedTech Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
